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Available online 24 November 2015Generating a diverse B cell immunoglobulin repertoire is essential for protection against infection. The repertoire
in humans can nowbe comprehensivelymeasured by high-throughput sequencing. Using hepatitis B vaccination
as a model, we determined how the total immunoglobulin sequence repertoire changes following antigen expo-
sure in humans, and compared this to sequences from vaccine-speciﬁc sorted cells. Clonal sequence expansions
were seen 7 days after vaccination, which correlated with vaccine-speciﬁc plasma cell numbers. These expan-
sions caused an increase in mutation, and a decrease in diversity and complementarity-determining region 3
sequence length in the repertoire. We also saw an increase in sequence convergence between participants 14
and 21 days after vaccination, coinciding with an increase of vaccine-speciﬁc memory cells. These features
allowed development of a model for in silico enrichment of vaccine-speciﬁc sequences from the total repertoire.
Identifying antigen-speciﬁc sequences from total repertoire data could aid our understanding B cell driven im-
munity, and be used for disease diagnostics and vaccine evaluation.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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mAbs1. Introduction
The human B cell immunoglobulin repertoire has the theoretical po-
tential to include up to 1011 unique variants (Glanville et al., 2009); such
diversity is key to confer immunity against the variety of antigens that
may be encountered during a lifetime. Upon antigen recognition, cog-
nate B cells become activated, proliferate, and differentiate to produce
short-lived antibody-secreting plasma cells (PCs) important in the ini-
tial response, and long-lived PCs and memory cells that contribute to
sustained immunity. The use of vaccines as a controlled model system
to study B cell responses is an important approach in human immunol-
ogy (Lambert et al., 2005). B cell responses to vaccination are conven-
tionally assessed by global measures of the quantity and function of
speciﬁc antibody in the blood, but these provide little insight into the
characteristics of the B cells responsible for producing the antibody, or, Department of Paediatrics,
search Center, Oxford OX3 7LE,
. Galson).
. This is an open access article undertheir kinetics over time. Understanding which B cells produce speciﬁc
antibody, and their kinetics in response to antigen encounter has appli-
cation in the ﬁeld of vaccine development and evaluation, and also in
assessing response to infection (Galson et al., 2014).
Antibody speciﬁcity is largely determined by the immunoglobulin
heavy chain gene sequence used by each individual B cell (Xu and
Davis, 2000). Recent improvements in throughput, and decreases in
cost of next-generation sequencing make it feasible to use this technol-
ogy to characterize the immunoglobulin heavy chain repertoire in large
numbers of samples. This approach has already yielded clinical applica-
tions in the monitoring of minimal disease residue in B cell lymphoma
patients (Boyd et al., 2009), and the rapid identiﬁcation of monoclonal
antibody sequences (Reddy et al., 2010), and has shown promise for in-
creasing understanding of autoimmune conditions (Palanichamy et al.,
2014) and in disease diagnostics (Parameswaran et al., 2013).
High-throughput immunoglobulin sequencing is now also being
applied to vaccine studies (Ademokun et al., 2011; Jiang et al.,
2013; Laserson et al., 2014; Trück et al., 2015; Vollmers et al., 2013;
Wang et al., 2014), and it appears possible to detect vaccine-induced
perturbations in the total repertoire that relate to the functional B cellthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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immunoglobulin repertoire diversity, there appears to be a degree of
sequence convergence across individuals for a given antigen. Conver-
gence has been seen seven days following vaccinationwith simple poly-
saccharide antigens (Trück et al., 2015), and more complex inﬂuenza
antigens (Jackson et al., 2014), as well as following dengue infection
(Parameswaran et al., 2013). It remains unclear how long perturbations
in the immunoglobulin repertoire can be detected following vaccina-
tion, and whether such perturbations in the global repertoire can be
used to identify the speciﬁc immunoglobulin sequences of the B cells
generating the response. The ability to de novo enrich for immunoglob-
ulin sequences with certain speciﬁcities from the total repertoire is
key for understanding speciﬁc B cell responses to vaccination, and
uncovering the clinical potential of this technology.
We used the response to hepatitis B (HepB) vaccination as a model
system to interrogate the global immunoglobulin heavy chain reper-
toire atmultiple time points up to onemonth followingbooster vaccina-
tion with monovalent HepB surface antigen (HBsAg; Fig. 1). We show
that the repertoire is variable between individuals, but that there are
distinct signatures seen seven days following vaccination that appear
to relate to the increase in the number of HBsAg-speciﬁc PCs in the pe-
ripheral blood at this time. We conﬁrm that there is an increase in
repertoire convergence present from at least day 14 until day 21 days
following vaccination, more in keeping with the kinetics of HBsAg-
speciﬁc memory cells in the peripheral blood. In addition to analyzing
sequences from total B cells, we performed cell sorting of HBsAg-
speciﬁc B cells and PCs, and sequenced these to investigate how their
repertoire characteristics related to the perturbations seen in the sam-
ples derived from unsorted B cells. Furthermore, the B cell repertoire
of HepB vaccine naïve participants was also sequenced, and differences
were found in this population compared to the previously vaccinated
population even at baseline. Using this information we were able to de-
velop a simple analytic model to enrich for HBsAg-speciﬁc sequences
from the repertoire data obtained from total B cells.
2. Materials & Methods
2.1. Sample Collection
Two groups with nine healthy subjects (aged 20–59) in each were
recruited with informed consent, under approval from theFig. 1. Study design. Two groups of participants were enrolled into the study: one group of nine
participants who had previously received a course of HepB vaccine (booster vaccine group). In
timepoint. In the booster vaccine group, total B cells were sorted and sequenced (IgG and IgM tr
4 participants), and 28 following vaccination. In addition, for 5 of theparticipants in this group,H
and PCs on day 7 following vaccination. Sequences from the HBsAg + sorted cells, and sorted
naïve group that appeared to have enriched speciﬁcity towards the vaccine.Northampton Research Ethics Committee (13/EM/0036). One group
consisted of participants with no prior HepB vaccine history (naïve
group), who had blood taken at a single timepoint (Fig. 1). The second
group consisted of participants who had previously received a primary
course of HepB vaccination (vaccine group). Participants in this group
were given a single intramuscular HepB booster vaccine containing
10 μg HBsAg, adsorbed on amorphous aluminum hydroxyphosphate
sulfate (HBvaxPRO®, Sanoﬁ Pasteur). Blood was taken immediately be-
fore vaccination as well as 7, 14, 21 and 28 days after vaccination. Blood
was transferred to a heparinized tube for processing within 4 h of
collection.2.2. Anti-HBs Testing
Blood serum was isolated by centrifugation, and tested for anti-HBs
IgG concentration by ELISA at the microbiology laboratory, John Rad-
cliffe Hospital, Oxford, UK.2.3. Enumeration of Plasma and Memory Cells by ELISpot
Peripheral blood mononuclear cells (PBMCs) were isolated from
blood by density-gradient centrifugation over lymphoprep (Asis-Shield
Diagnostics). Cultured and ex-vivo ELISpot assays were conducted from
the PBMCs to detect antigen-speciﬁc memory and PCs respectively,
using a previously described protocol (Clutterbuck et al., 2012). Brieﬂy,
MultiScreen-IP 96-well plates (Millipore) were coatedwith 2.5 μg/ml of
puriﬁed HBsAg (GSK). For enumeration of HBsAg-speciﬁc PCs, 200,000
PBMCs were placed in each well, and incubated overnight. Cells were
thenwashed from the plate, and IgG antibody bound to the plate detect-
ed using the AP conjugate substrate kit (Bio-Rad). For enumeration of
HBsAg-speciﬁc memory cells, PBMCs were ﬁrst cultured in RPMI
(Sigma-Aldrich) containing 1/10 NBBS, 1/5000 Staphylococcus aureus
cowans strain, 1/6000 pokeweed mitogen (Sigma-Aldrich) and 1/40
CpG class B oligonucleotide (5′-tcgtcgttttgtcgttttgtcgtt-3′; InvivoGen)
for 6 days to activate antibody secretion. 200,000 cultured cells were
added to each well of the plate, and detected in the same way as the
ex-vivo cells. Spot counting was performed automatically using the
AID ELISpot Reader System (AID Autoimmun Diagnostika). For each
sample, 6 wells were seeded in parallel, and themean spot count taken.participants with no previous HepB vaccine history (naïve group), and one group of nine
the naïve group, total B cells were sorted and sequenced (IgG transcripts only) at a single
anscripts) on the day of HepB booster vaccine, and on days 7, 14, 21 (samplesmissing from
BsAg+B cellswere isolated and sequencedondays7, 14, 21 and28 following vaccination,
PCs were used to ﬁnd sequence clusters in the total repertoire of both the vaccinated and
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B cells were enriched from PBMCs using CD19microbeads (Miltenyi
Biotec), and the AutoMACS Pro cell separator, and counted using a
hemocytometer. 500,000 B cells were isolated for sequencing the total
repertoire. In the vaccine group, remaining B cells were labeled with
Live/dead-Aqua, CD19-FiTC, CD20-APCH7, CD27-PECy7, CD38-PE,
HLA-DR-PerCpCy5 and HBsAg-APC. Viable, CD19+, CD20+,
HBsAg + B cells and viable CD19+, CD20−, CD27+, CD38+, HLA-
DR+ PCs were then isolated using a MoFlo cell sorter (Beckman Coul-
ter). For competition experiments, unconjugated HBsAg was also
added to the labeling mixture. Sorted cells were frozen in RLT buffer
(Qiagen) at−80 °C prior to repertoire sequencing.
2.5. Repertoire Sequencing
RNA was extracted from sorted cells using the RNeasy Mini Kit
(Qiagen), and reverse transcription performed using SuperScript III
(Invitrogen), and random hexamer primers (42 °C for 60 min, 95 °C
for 10 min). PCR was conducted using the Multiplex PCR kit
(Qiagen), and 200 nM VH-family speciﬁc forward primers, with
IgM and IgG-speciﬁc reverse primers in separate reactions (Wu
et al., 2010) (94 °C for 15 min, 30 cycles of 94 °C for 30 s, 58 °C for
90 s and 72 °C for 30 s, and 72 °C for 10 min). Amplicons were gel-
extracted and puriﬁed prior to MiSeq library preparation. Samples
were multiplexed, and sequenced across four 2 × 300 bp MiSeq runs.
2.6. Raw Sequence Processing
Sequences from each input sample were de-multiplexed, and paired
ends joined using fastq-join (ea-utils). After ﬁltering for a minimum
Phred quality of 30 over 75% of bases, sequences were submitted to
IMGT/HighV-Quest (Brochet et al., 2008) for annotation. There was
then further ﬁltering for reads deﬁned as productive by IMGT. Total
repertoire samples were normalized by random subsampling to
100,000 sequences per sample. Sequences from HBsAg+ and PC+
samples were pooled, and sequences with duplicate complementarity-
determining region (CDR) 3 amino acid (AA) sequences removed.
2.7. Sequence Clustering
Sequences from total repertoire samples and naïve samples were
clustered into clonal lineages based on CDR3 AA sequence similarity
and V and J gene segment usage, using a previously described method
(Galson et al., 2015). To be included in the same cluster, sequences
had to have the same length CDR3 AA sequence, with no more than 1
mismatch per 12 AA's and use the same V and J gene segments. This
threshold will include both clonally related sequences, and similar se-
quences arising from PCR error (Galson et al., 2015). Samples from all
participants and timepoints were clustered together to allow easy com-
parison of clusters between participants and over time. The contribution
of sequences to each clusterwasdetermined separately for each sample,
so that the data could subsequently be split by sample.
2.8. Cluster-level Annotation
For each sample, clusters were annotated for their CDR3 AA se-
quence length, V and J gene segment usage, the total number of se-
quences in the cluster, the number of unique CDR3 AA sequences in
the cluster, and the average number of V gene mutations of the se-
quences in the cluster. The frequency of each cluster in each sample
was also calculated by dividing the total number of sequences in the
cluster by the total number of sequences for the sample andmultiplying
by100. Clusterswere deﬁned as shared between samples if each sample
contributed at least one sequence to the cluster. Sequences from
HBsAg+ and PC+ sorted cells were then compared to clustered datato seewhich clusters theywould fall into— these clusters were then an-
notated appropriately. For this comparison, the HBsAg+ and PC+ se-
quences were only matched back to participants from whom those
sequences were not obtained in order to reduce the effect of non-
speciﬁc matching. In addition, sequences from previously described
TT-speciﬁc (Dekosky et al., 2013; Frölich et al., 2010; Lavinder et al.,
2014; Poulsen et al., 2011) and inﬂuenza-speciﬁc mAb sequences
were compared to the clustered data in the same way.
2.9. Repertoire-level Annotation
Mean CDR3 AA length and number of V genemutations were calcu-
lated for the entire repertoire of each sample; for these calculations,
clusters were weighted according to the number of sequences they
contained. Repertoire diversity was calculated using Shannon's diversi-
ty index from ecology, where each cluster is considered a distinct spe-
cies (Stewart et al., 1997).
2.10. Statistical Analysis and Graphing
Statistical analysis was performed using R (R Development Core
Team, 2008), with ggplot2 (Wickham, 2009) for graphing. Principal
component analysis was performed using the prcomp function in the
‘stats’ package. T-tests or Mann–Whitney U tests were used where ap-
propriate to compare groups. Correlations were calculated with Spear-
man or Pearson correlation coefﬁcients where appropriate.
Correlations were graded as low (r values between 0.2–0.39), moderate
(0.4–0.59), strong (0.6–0.79), and very strong (≥0.8).
3. Results
3.1. Serological and Cellular Measures of Vaccine Response
All nine previously vaccinated participants had an increase in anti-
HBs antibody concentration to greater than 100 mIU/ml by day 28 fol-
lowing vaccination (p = 0.0039), There was considerable inter-
individual variation in both the pre-vaccination and post-vaccination
antibody concentrations (Fig. 2A/C). HBsAg-speciﬁc IgG PC numbers in
the peripheral blood, as determined by ELISpot, peaked 7 days following
vaccination in all participants (mean 99, range 2–208 PCs/106 PBMCs),
and were present at negligible numbers on all other days (Fig. 2B/D).
HBsAg-speciﬁc IgG memory cell frequency, as determined by ELISpot,
peaked at a later timepoint than the PCs; the greatest number were
seen 28 days following vaccination (mean 72, range 0–163 memory B
cells/106 cultured lymphocytes). Day 7 PC numbers were strongly cor-
related both with day 28 memory B cell numbers (Spearman r = 0.77,
p = 0.0214; Fig. 2E), and the absolute increase in antibody concentra-
tion between day 0 and day 28 (Spearman r = 0.87, p = 0.0045;
Fig. 2F). The nine participants with no prior HepB vaccine history
(naïve group) had noHBsAg-speciﬁc IgGmemory cells or PCs detectable
by ELISpot.
3.2. High-throughput Sequencing of the Total Immunoglobulin Repertoire
Sequence data were obtained for total IgG and IgM transcripts from
all nine vaccinated participants on day 0, 7, 14 and 28, and fromﬁve par-
ticipants also at day 21. On average 365,863 (range 203,151–1,023,663)
raw reads were obtained per sample (Table S1). After processing and
QC, this dropped to 282,432 (109,499–1,195,321) per sample, of
which 100,000 per sample were randomly subsampled for normaliza-
tion and then used for further analysis. This gave a total of either
1,000,000 or 800,000 total sequences for each participant depending
on the availability of day 21 samples. Following clustering, there were
on average 14,560 (1604–26,375) clusters per sample for the IgG
dataset, and 55,612 (19,088–79,102) clusters per sample for the
IgM dataset. In addition, sequence data were obtained for total IgG
Fig. 2. Clinical measures of vaccine response. (a) Anti-HBs antibody concentrations of each participant at day 0 and day 28 following vaccination. (b) Kinetics of HBsAg-speciﬁc memory
cells and PC numbers during the study period determined by ELISpot. Input cells are PBMC's for the PC detection assay, and cultured lymphocytes for thememory cell detection assay. (c &
d) Same as a and b, but displayingmean values± SEM of the nine participants. (e) Correlation between HBsAg-speciﬁc PC numbers at day 7, and HBsAg-speciﬁc memory cell numbers at
day 28. (f) Correlation betweenHBsAg-speciﬁc PCnumbers at day 7, and the absolute increase in antibody concentration between day 0 and 28. For e and f, rho represents Spearman's rank
correlation coefﬁcient.
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(277,691–342,026) raw reads, and following subsampling to
100,000 ﬁltered reads, 11,605 (4712–22,701) clusters for each sam-
ple (Table S2).
Samples were then characterized based on the total repertoire met-
rics of diversity (calculated using Shannon's diversity index), average V
gene mutation, and average CDR3 AA sequence length; these are met-
rics previously noted to be associated with the degree of differentiation
of B cell populations, and were used for initial sample quality control
and outlier detection (Galson et al., 2015). Principal component analysis
(PCA) based on these metrics showed that IgG and IgM samples clus-
tered independently, but IgG samples from the naïve group did not ap-
pear different to IgG samples from the vaccinated group (Fig. S1).
However, most day 7 IgG samples in the vaccinated group had distinct
features compared to the rest of the IgG samples; this was not so appar-
ent in the IgM dataset. The day 0 IgG and IgM samples from participant
1368 appeared to be outliers. In addition, all IgM samples from partici-
pant 1070 were distinct from the rest of the IgM samples, and appeared
to cluster more with the IgG samples.
3.3. Repertoire Expansions are Greatest 7 days Post-vaccination, and
Correlate with PC Numbers
To visualize the degree of clonal expansion in the repertoire, the top
200most frequent clusters were ﬁrst selected from each sample. Taking
the top 200 clusters is a conservative method to include all expanded
clusters in the repertoire present at a frequency greater than 0.1%
(Fig. 3A). Determining the frequencies of these clusters at each
timepoint allowed us to track their kinetics over the course of the
study (Figs. 3B & S2). Although therewas great inter-individual variabil-
ity in the kinetics of their large clusters, nearly all participants had a de-
gree of expansion 7 days following vaccination. In general, day 7 cluster
expansionsweremore pronounced in IgG than IgM repertoires. Of note,the repertoire of participant 1368 appeared to contain a large number of
clonal expansions on the day of vaccination, and the repertoire from
participant 1070 had a number of large expanded clusters that were
present at all timepoints both in the IgG and IgM dataset (Fig. S2).
Both datasets also contained a single expanded cluster present at a fre-
quency greater than 10% at all timepoints (although the identiﬁcation of
this cluster was different in the IgG compared to IgM dataset). Based on
the ﬁnding of clonal expansions at day 0, and being an outlier by PCA,
participant 1368 was excluded from downstream analysis due to
suspected immune activation at day 0.
To quantify the degree of expansion in each sample, we then found
the top 200 most frequent clusters from each timepoint individually
for each participant. The proportion of the total repertoire the 200 larg-
est clusters accounted for was then calculated (Fig. 3C). Although the
top 200 clusters comprise only a small percent of the total number of
clusters (mean 1.3% for IgG and 0.4% for IgM), sequences contained in
these clusters account for a large percentage of the total repertoire
(mean 55% for IgG and 16% for IgM). The percentage of the repertoire
comprised by these expanded clusters increased 7 days following vacci-
nation (p = 0.0124) for the IgG dataset, and then decreased back to a
baseline-like state by 14 days following vaccination. There was no sig-
niﬁcant change in the percent of the repertoire comprised by these ex-
panded clusters at any day in the IgM dataset. The fold change in the
number of expanded clusters (present at a frequency greater than
0.1%) between day 0 and day 7 was strongly correlated, with the num-
ber of HBsAg-speciﬁc PCs in the peripheral blood 7 days following vac-
cination (r = 0.70, p = 0.0511; Fig. 3D).
3.4. Day 7 Repertoire Expansions Impact Total Repertoire Properties
Based on the total repertoire metrics of diversity, average V gene
mutation, and average CDR3 AA sequence length, IgM samples were
more diverse, less mutated, and had longer CDR3 AA sequences
Fig. 3. Day 7 repertoire expansions. (a) Histogram of the most frequent 1000 clusters or-
dered by frequency. Bars represent mean values of samples from all 41 samples. Vertical
lines cross the x-axis at cluster number 200, and horizontal lines cross the y-axis at 0.1%
(representing clusters containing 100 sequences). (b) Representative cluster kinetics
plot from participant 1066 for their IgG repertoire (see Fig. S2 for plots from all partici-
pants). The 200 most frequent clusters at each day were found for this participant, and
the frequencies of these clusters were plotted as a stacked bar chart, centered to the mid-
dle of the y-axis at each day. Clusters from each day were then joined using a horizontal
stream to illustrate how the frequency of the clusters changes over time. The width and
darkness of the stream represents the frequency of the cluster at that time. (c) Mean per-
cent of the total repertoire comprised by the top 200 most frequent clusters at each day.
Error bars indicate ± SEM from 8 participants. P value represents the result from a t-
test. (d) Correlation between day 7 PCnumbers, and the fold change in thenumber of clus-
ters present at a frequency greater than 0.1%. r represents the Pearson product–moment
correlation coefﬁcient.
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cant changes in these features over the course of the study for
the IgM dataset. For the IgG dataset, the repertoire became less di-
verse (p = 0.0320), more mutated (p = 0.0446), and had a shorter
average CDR3 AA length (p = 0.0078) at day 7 compared to day 0(Figs. 4A–C & S1), consistent with increased B cell stimulation at
day 7. There were no differences between day 0 and any of the
other timepoints.
The dataset for each sample was then split into the 200 most fre-
quent clusters, and the remaining clusters, and the total repertoire met-
rics calculated for the split dataset (Fig. 4A–C, blue and green). The 200
most frequent clusters were less diverse, more mutated, and had a
shorter average CDR3 AA length than the remaining clusters. In addi-
tion, the 200 most frequent clusters for the IgG samples became even
less diverse, more mutated, and had shorter CDR3 AA length at day 7
compared to day 0; this difference between day 0 and day 7 was not
seen for the remaining less frequent clusters. It therefore appears to
be the frequent clusters that drive the changes seen in the total reper-
toire at day 7, but even without enriching for these frequent clusters it
is still possible to determine changes in the metrics of the total reper-
toire at day 7.
3.5. Repertoire Convergence Between Individuals Peaks 14–21 days After
Vaccination
To investigate repertoire convergence following vaccination, we
compared every participant to every other participant to see how
many clusters were shared between each pair of two participants
(Fig. 5). This was relatively low at day 0 (mean of 20 (0.07%) for
IgG and 601 (0.53%) for IgM). The number increased following vacci-
nation, and peaked at day 21 (mean of 45 (0.11%) for IgG and 806
(0.61%) for IgM). For IgM, the increase in sharing from day 0 was
only signiﬁcant for day 14 (p b 0.0001), but for IgG the increase
in sharing was signiﬁcant for days 14 (p = 0.0014) and 21 (p b
0.0001). Shared clusters were more mutated (for IgG only), had
shorter CDR3 AA regions, and comprised a larger proportion of the
total repertoire than the clusters that were unique to a single partic-
ipant (Fig. S3).
3.6. Generating a Database of Enriched Vaccine Antigen-speciﬁc Clusters
We used a ﬂuorescence-activated cell sorting (FACS) approach,
using HBsAg conjugated to APC, to isolate and sequence HBsAg + B
cells (Fig. 6A). The speciﬁcity of staining was shown to be at least 50%
by competition with unconjugated HBsAg (Fig. 6B). In total, 85,000
HBsAg + B cells were isolated after vaccination from ﬁve of the partic-
ipants included in this study (Table S3). FACS was also used to isolate
a total of 3444 PCs at day 7 (PC+) from the same ﬁve participants
(Table S4), on the basis that these are likely to be signiﬁcantly enriched
for HBsAg speciﬁcity. Sequences from these cells were then matched
back to the total IgG repertoire of both the vaccinated and naïve partic-
ipants, and clusters annotated as HBsAg+or PC+based onwhether se-
quences from the sorted cell datasets matched to them. To reduce the
effect of sequences from non-speciﬁcally stained cells, sequences were
only matched back to participants from whom those sequences were
not obtained. The probability of any two individuals sharing a given ran-
domly selected sequence is very low, so sequences are unlikely tomatch
to the repertoire of a different individual unless they are speciﬁc to the
common stimulus (HBsAg). Thismatching technique therefore provides
an additional method for enriching for vaccine-speciﬁcity within the
stained cells. Of the 482,849 total clusters in the vaccinated participants,
1129 were annotated as HBsAg + clusters and 235 were annotated as
PC+ clusters. In the naïve participants, there were 104,473 total clus-
ters, of which 151 were annotated as HBsAg+, and 101 as PC+. In
total, there were 63 clusters that were annotated as both the HBsAg+
and PC+, which is signiﬁcantly more than expected by chance (ﬁshers
exact test; p b 0.0001).
In addition to the vaccine antigen-speciﬁc HBsAg+ and PC+ clus-
ters identiﬁed by FACS, a database of sequences speciﬁc for antigens un-
related to the HepB vaccine antigen was generated as a control dataset
by a literature search. Tetanus toxoid (TT) and inﬂuenza-speciﬁc
Fig. 4. Expansion-induced changes in diversity, mutation, and CDR3 AA length. Changes in
mean repertoire diversity (measured using Shannon's index with each cluster considered
a distinct species) (a), mean number of V genemutations from all sequences in the reper-
toire (b), and mean CDR3 AA sequence length from all sequences in the repertoire (c).
Mean ± SEM shown for 8 participants; black points are values from the total repertoire,
green are from sequences containedwithin the 200most frequent clusters from that sam-
ple, and blue are from the remaining clusters. P value represents the result from a t-test
comparing day 0 and day 7 values from the total repertoire.
2075J.D. Galson et al. / EBioMedicine 2 (2015) 2070–2079sequences were chosen, as there is the largest body of public data for
these sequences. Sixteen inﬂuenza-speciﬁc sequences, and 32 TT-
speciﬁc sequences were found that mapped to clusters in our dataset
(Table S5).Fig. 5. Repertoire convergence. At each day, the percent of clusters shared by each pair of
two participants was determined (8 participants, giving 28 different pairings). Shown are
themean values± SEMof the percent of clusters shared between each pair. Percent is cal-
culated as (A∩B/sum(A,B) ∗ 100. P values represents the result from a t-test comparing
day 0 and day 7 values from the total repertoire.3.7. Vaccine Antigen-speciﬁc Clusters Increase in Number and Size After
Vaccination
Based on the database of enriched antigen-speciﬁc clusters,
HBsAg+, PC+ and TT+ or inﬂuenza + clusters were searched for in
each sample. In addition to these antigen-speciﬁc clusters, we also gen-
erated sets of randomly selected clusters (including the same number of
clusters as the antigen-speciﬁc sets) from our IgG repertoire data to be
used as a control. Therewas a peak in the percent of total clusters anno-
tated as either HBsAg+or PC+at day 7 following vaccination (Fig. 6C &
D). This was more pronounced for the PC+ clusters than the HBsAg +
clusters, and not seen when searching for the randomly sampled set of
clusters. Correcting for cluster size showed an even more marked peak
at day 7 for both the HBsAg+ and PC+ clusters (Fig. 6E & F). There
were no distinct changes in the numbers of irrelevant TT+ or inﬂuen-
za + antigens following vaccination (Fig. 6G & H), although the num-
bers of these clusters identiﬁed was low at all timepoints due to
limitations in the number of previously published sequences we could
ﬁnd.
Despite considerable inter-individual variation, the clusters annotat-
ed as HBsAg+ or PC+ in the previously vaccinated participants were
more mutated, had greater frequency, and had shorter CDR3 sequences
than those not annotated (Fig. S4). In the naïve participants, there was
no difference between the HBsAg+ and non-annotated clusters in mu-
tation or frequency, but the HBsAg + clusters still had signiﬁcantly
shorter CDR3 length than the non-annotated clusters.
3.8. Bioinformatic Enrichment of Vaccine Antigen-speciﬁc Clusters from the
Total Repertoire
Based on the total repertoire signatures observed, and the properties
of the vaccine antigen-speciﬁc clusters, we developed amodel to enrich
for vaccine-activated clusters (i.e., likely to be HBsAg-speciﬁc, but could
potentially be speciﬁc to an irrelevant antigen due to bystander activa-
tion) from the total repertoire.We focused on the IgG dataset, as the sig-
nals were stronger, and class-switched cells dominate the response to
booster vaccination (Blanchard-Rohner et al., 2009). From the data
analysis and a priori consideration of features likely to be associated
with a response to vaccination we used the properties of cluster fre-
quency, mutation number and cluster sharing to develop amodel to en-
rich for vaccine antigen-speciﬁc clusters. The model did not require
having a short CDR3 sequence, as this may not be a universal property
of all antigens, so not useful outside of the context of this speciﬁc vac-
cine. Additionally, the HBsAg+ and PC+ clusters present in the naïve
participants were also short, so this may just be due to chance. Conser-
vative cutoff values of more than 18mutations, and a frequency greater
than 0.01% (i.e. minimum of 10 sequences in the cluster) were set based
on the distributions of these variables (Fig. S5). Searching for clusters
that ﬁt all three requirements on each day showed that there were
133 present in the naïve participants compared to 65 present in the pre-
viously vaccinated participants at day 0 (Fig. 7A); however, these popu-
lations are not directly comparable, as there were nine participants in
the naïve group compared to eight in the previously vaccinated group,
so there will be more shared sequences by chance in the naïve group.
The number of clusters that ﬁt all three requirements increased at
each successive visit following vaccination up to 114 clusters at day 28.
To validate our model for identifying clusters likely to contain
vaccine-speciﬁc sequences, we compared the clusters identiﬁed in the
model to those annotated as HBsAg+ or PC+ based on the FACS data
(Fig. 6B). This was done separately for each metric in the model. By
combining the metrics of sharing, mutation, and frequency, it was pos-
sible to obtain greater enrichment for vaccine-speciﬁc clusters than
using either of these metrics on their own. Despite identifying more
clusters that ﬁtted the model parameters in the naïve group, these
were less enriched for HBsAg+ or PC+ speciﬁcity than those from
the vaccinated group even at day 0 (9.2% HBsAg+ and 9.2% PC+ in
Fig. 6. Kinetics of antigen-speciﬁc clusters. (a) FACS gating strategy for isolating HBsAg + B cells and PCs from CD19+ enriched cells. (b) Results from competition experiment where
unconjugated HBsAgwas added to the antibodymix at the same time as the HBsAg-APC.Mean and±SEM shown for three tests of each condition. (c) Of the 1360 total clusters annotated
asHBsAg+based on the sequence data from sorted cells, the number of these in eachparticipant at eachdaywas determined, and expressed as a percentage of the total number of clusters
present in that participant at that day. In addition, a random sample of 1360 clusters was also taken from the dataset, and the same calculation done as a control. (d) Percent of the total
repertoire comprised by the clusters identiﬁed in a (ie, corrected for cluster size). (e& f) show the same as c &d, butwith the 289 clusters annotated as PC+. (g &h) show the same as c &d,
but with the 65 clusters identiﬁed in our dataset that matched to previously described sequences speciﬁc for either TT or inﬂuenza. For all plots, horizontal bars show the median value
from either the 8 vaccinated participants or the 9 naïve participants.
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the naïve group). The greatest enrichmentwas seen at day 7, where 22%
of the 78 enriched clusters were annotated as HBsAg+ and 24% anno-
tated as PC+. The model therefore gave 42× enrichment for HBsAg +
clusters, and 168× enrichment for PC+ clusters at day 7, compared to
looking at total clusters. Following day 7, the degree of enrichment de-
creased at each subsequent timepoint sampled. Considering eachmetric
independently, shared clusters contained the highest percentage of
HBsAg+ and PC+ clusters, followed by frequent clusters, and ﬁnally
mutated clusters. The kinetic of the enrichment seen in the shared clus-
ters was also slightly different to that of mutated or frequent clusters, as
there was an increase seen again at day 28.
4. Discussion
Using HepB booster vaccination as a model system, we applied in-
depth sequence analysis of the immunoglobulin heavy chain repertoire
from circulating B cells to thoroughly characterize how the B cell reper-
toire responds to secondary antigen encounter. Although antigen-
speciﬁc B cells account for only a small proportion of the total peripheral
B cells even at the peak of their appearance, wewere able to detect per-
turbations in global repertoire properties 7 days following vaccination.These changeswere characterized by a decrease in diversity, an increase
inmutation, and a decrease in CDR3 sequence length— features that ap-
pear to be generally characteristic of more activated B cells (Galson
et al., 2015), and can be related to the appearance of vaccine-induced
PCs in the peripheral blood at this time. These changes were only seen
in the IgG dataset, which is to be expected, as this is a secondary re-
sponse so will be stimulating switched memory cells. Interestingly,
despite these perturbations being most pronounced 7 days after vacci-
nation, the greatest sequence similarity between the repertoires of dif-
ferent individuals was seen on days 14 and 21 after vaccination.
Although day 7 repertoire perturbations have previously been ob-
served (Jackson et al., 2014; Laserson et al., 2014; Wang et al., 2014),
to our knowledge the repertoire similarity on days 14 and 21 have not
been previously studied. The minimal repertoire overlap we observe
at day 0 is to be expected considering the enormous diversity of the rep-
ertoire, and our sampling depth of 100,000 reads (Boyd et al., 2009;
Galson, 2015). Given the diversity of the immunoglobulin repertoire,
the ﬁnding of two identical CDR3 AA sequences in 2 different individ-
uals is unlikely to occur by chance alone (Saada et al., 2007), so could
be indicative of common selection pressures on the repertoire of
different individuals. The increase in convergencewe see following vac-
cination is in line with the vaccine antigen either imposing such a
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different individuals to produce sequences speciﬁc for the antigen, or
simply expanding pre-existing memory cells that have already been
selected in this way. Such antigen-driven convergence has been seen
following immunization with highly repetitive polysaccharide antigens
(Trück et al., 2015), and also in the context of inﬂuenza vaccination
(Jackson et al., 2014). Both of these studies investigated convergence
7 days following vaccination, as this coincides with the peak of PCs in
the peripheral blood in a secondary response, so is expected to give
the greatest signal. Our study conﬁrms that convergence is also seen
in the context of a simple protein antigen (with Alum adjuvant), but
by sampling atmore timepoints, shows that the increase in convergence
at day 7 is relatively minor, and instead the most signiﬁcant signals are
seen on days 14 and 21. The kinetics of the increase in convergence is
therefore more in line with the kinetics of vaccine-speciﬁc memory
cells in the peripheral blood rather than PCs. One interpretation of this
is that following vaccination there is rapid activation of circulating
memory cells to terminally differentiate into low-afﬁnity PCs by day 7,
as demonstrated by the greatest repertoire expansions seen in our
study. However, it is likely that there is also formation of germinal cen-
ters, which mediate further proliferation and selection for antigen
binding, and the production of higher-afﬁnity memory cells at later
timepoints (Bachmann et al., 1996; Mcheyzer-williams et al., 2015).
The small increase in convergence at day 7 may therefore be a result
of low-afﬁnity PC sequences, while the increased convergence later on
may be a result of the higher-afﬁnity memory cell sequences. Although
we do not see an increase in convergence at day 28 when there are the
greatest numbers of circulatingmemory cells detectable by ELISpot, this
may be because the circulating memory cells are all clonally related by
this time, so sequences derived from these cells would all be incorporat-
ed into a single sequence cluster. Alternatively, this may be an artifact of
the stimulation method used for memory cell detection by ELISpot in
that the day 28memory cells are more readily stimulated to secrete an-
tibody than earlier memory cells. Nevertheless, these results suggest
that careful consideration of timepoints should be takenwhenusing im-
munoglobulin repertoire sequencing to ﬁnd mAb sequences. Normally,Fig. 7.Bioinformatic enrichment of vaccine-speciﬁc clusters from the total repertoire. (a) Vennd
mutated (more than 18 V genemutations on average), and frequent (more than 0.01% of the to
participants. Day 21 is omitted, as therewereno samples from fourof theparticipants at this tim
category by the total number of clusters at that timepoint. (b) In each category in the Venn diag
FACS data was determined.day 7 PCs are isolated and sequenced, but the resulting mAbs can be of
low afﬁnity (Reddy et al., 2010; Wrammert et al., 2008); if later
timepoints were instead chosen and the memory cell sequences identi-
ﬁed, it may be possible to generate higher afﬁnity mAbs.
By sorting and sequencing HBsAg + (memory) and PC+ cells, we
were able to conﬁrm that cells speciﬁc to the vaccine caused the signa-
tures we saw in the repertoire. Both the HBsAg+ and PC+ clusters had
increased convergence, mutation, and size compared to the total reper-
toire, and tracking the kinetics of these clusters showed the greatest
peak at day 7. Based on our observations of what comprises a vaccine-
speciﬁc cluster, wewere able to create a simplemodel for de novo iden-
tiﬁcation of such clusters from the total repertoire. Although cluster ex-
pansion alone appears to be sufﬁcient to identify likely day 7 PC clusters,
adding in the metrics of cluster sharing and cluster mutation improved
enrichment of vaccine-speciﬁc clusters present at other timepoints. It
may also be possible to identify different types of cells (memory cells
vs PCs) by considering differentmetrics. By looking atwhether the clus-
ters identiﬁed were indeed annotated as HBsAg+ or PC+ by compari-
son to sequences from the sorted cells, we were able to validate the
model.
We are unable to determine speciﬁcity of the model, as we will not
have sorted and sequenced the entire vaccine antigen-speciﬁc reper-
toire, so there may be more clusters in the enriched population that
are vaccine antigen-speciﬁc, but were not annotated as such. An addi-
tional limitation was that the HBsAg + cell sorting only had approxi-
mately 50% speciﬁcity. Furthermore, for the PC+ cell sorting, although
we focused on HLA-DR+ PCs, as these are a recently activated popula-
tion that will be enriched for vaccine-speciﬁcity (Odendahl et al., 2005),
we cannot rule out that some of the PCswill have alternate speciﬁcities.
Indeed, this appears quite likely, as even the naïve participants had clus-
ters annotated asHBsAg+andPC+.However, by onlymatching the se-
quences back to the repertoire of individuals fromwhom the sequences
were not obtained, this speciﬁcity should be increased, as the sequences
are unlikely to match to the repertoire of a different individual unless
they are speciﬁc to the common antigen. We are unable to clone and
functionally conﬁrm the speciﬁcity of these sequences, as we are justiagrams showing the overlap in the number of the shared (bymore than two participants),
tal repertoire) clusters at each day from the 8 vaccinated participants, and also the 9 naïve
epoint. Percentages are calculated bydividing thenumber of clusters present in a particular
rams, the percent of the sequences that were annotated as HBsAg+ or PC+ based on the
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express them with. Currently paired heavy:light chain sequencing is
technically challenging to perform in high throughput, although since
conducting this study, there have been signiﬁcant advances in this
area, offering promise for future work (DeKosky et al., 2015).
Despite the limitations, we show that with sufﬁciently stringent pa-
rameters, it appears possible to enrich for antigen-speciﬁc sequences in
populations that have encountered a common antigen, and that this is
possible at least 28 days following antigen encounter. However, it
must also be noted that themodel also enriched for HBsAg-speciﬁc clus-
ters at baseline before the participants had received the common
stimulus. Thismay be due to all participants having been previously im-
munized with HepB vaccine, making it possible to detect historic
HBsAg-speciﬁcmemory cells. Indeed, this signal appears greater in indi-
viduals previously immunized with HepB, compared to the unimmu-
nized naïve group.
The ability to de novo enrich for antigen-speciﬁc sequences (even if
not 100% speciﬁcally), has important clinical implications (Galson et al.,
2014). In the context of vaccination, identifying the responding se-
quences can be used to identify mAbs as previously mentioned. In addi-
tion, numbers of these sequences could potentially be used for novel
correlates of vaccine-mediated immunity (Trück et al., 2015); although
we could correlate expanded clusters with PC numbers in this study,
studies with larger numbers of participants are required to further val-
idate this. In the context of disease, in many cases, there are no deﬁni-
tive diagnostic tests. If common sequences or repertoire signatures
could be identiﬁed between individuals with certain diseases, these
could be used as diagnostic candidates. Here, it is necessary that the
signatures in the repertoire be persistent, and not limited to day 7 fol-
lowing antigen encounters.
Whilst we were able to identify common signatures that were
associated with a robust B cell response and could be used to identify
vaccine-speciﬁc clusters, there was considerable inter-individual varia-
tion in the global repertoire properties, and response dynamics in
different individuals, which can give tailored insight into individual
responses. For example, there was one participant (1212) who did not
have a peak of PCs appearing in the peripheral blood at day 7, but did
have an increase in anti-HBs in the blood, so must have produced
vaccine-speciﬁc PCs at some time during the study period. Sampling at
day 7 may have missed the PC burst in the peripheral blood (Henn
et al., 2013), or we may have been limited by the sensitivity of the
ELISpot assay. At the sequence level, there were clear day 7 clonal ex-
pansions in this participant, and these expansions were actually greater
than in other participants. It could be the case therefore that this partic-
ipant just produced a small number of PCs (undetectable by ELISpot),
but that these PCs produced large amounts of antibody (consistent
with the large clonal expansions). In addition, we noticed in one partic-
ipant (1070), that there was a highly expanded cluster (N10% of total
repertoire) present at every timepoint in both the IgG and IgM dataset.
We can speculate that such an expansion may be caused by chronic in-
fection (Wang et al., 2013) such as from cytomegalovirus, and although
this was not formally tested, it highlights the additional immunological
insights that can be gained from this sequencing technology. We note
that analysis of the enriched vaccine-speciﬁc sequence repertoire of
this participant revealed one of the strongest day 7 signals, which is in-
teresting in light of recentwork suggesting some chronic infectionsmay
enhance the immune response to vaccination (Furman et al., 2015).
To summarize, we have used immunoglobulin heavy chain reper-
toire sequencing, for a thorough dissection of the post-vaccination B
cell response.We showday 7 repertoire signatureswhich appear to cor-
relate with the PCs appearing at this time, and we show repertoire con-
vergence increasing up to day 21 following vaccination, which has a
more similar kinetic to appearance ofmemory cells.Measuring such sig-
natures can give a detailed insight of an individual's response to vacci-
nation, and may be applicable to studies of vaccine immunogenicity
and function. In addition, the knowledge of these signatures allowedthe development of a simple model to enrich for vaccine-speciﬁc clus-
ters from the total repertoire. Such ability to identify sequences of im-
portance in the response is key for fully utilizing the potential of this
technology to understand immune responses to disease and
vaccination.
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